Maen M Masadeh, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Masadeh’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A153638 · Current
Licensed to practise in California · since 2018 · expires 2027-10-31 · Faculty of Medicine, Jordan University of Science & Technology.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas BP10044545Physician-in-Training Permit · since 2012 · expires 2015-06-30Permit TerminatedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$43,710
Pharmacies billed $43,710 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
201 generic and 21 brand-name prescriptions · $43,710 in drug cost · 51 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gavilyte-C | 70 | $1,567 | $22 |
| Omeprazole | 31 | $312 | $10 |
| Amoxicillin-Clavulanate Potass | 18 | $243 | $14 |
| Ciprofloxacin | 18 | $137 | $8 |
| Amitriptyline | 12 | $70 | $6 |
Year by year
| 2024 | 222 | 136 | None | 9% | $43,710 |
| 2023 | 211 | 140 | 0% (0) | 14% | $53,745 |
| 2022 | 213 | 126 | 0% (0) | 14% | $37,427 |
| 2021 | 247 | 146 | 0% (0) | 24% | $55,542 |
| 2020 | 170 | 110 | 0% (0) | 17% | $46,106 |
| 2019 | 112 | 95 | 0% (0) | 11% | $14,433 |
| 2018 | 108 | 37 | 0% (0) | 14% | $16,792 |
| 2017 | 136 | 64 | None | 8% | $17,242 |
| 2016 | 128 | 44 | 0% (0) | 13% | $102,347 |
| 2015 | 292 | 50 | None | 15% | $15,045 |
| 2014 | 238 | 71 | None | 21% | $16,720 |
| 2013 | 337 | 82 | 4% (14) | None | $26,229 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Gavilyte-C | 66 | $1,384 | $21 |
| Omeprazole | 39 | $375 | $10 |
| Ciprofloxacin | 30 | $205 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $183 | $14 |
2022: 7 drugs
| Gavilyte-C | 49 | $849 | $17 |
| Cholestyramine | 11 | $578 | $53 |
| Amoxicillin-Clavulanate Potass | 11 | $480 | $44 |
| Dicyclomine | 28 | $301 | $11 |
| Peg-3350 and Electrolytes | 13 | $259 | $20 |
| Omeprazole | 24 | $229 | $10 |
| Ciprofloxacin | 33 | $224 | $7 |
2021: 7 drugs
| Creon | 16 | $46,444 | $2,903 |
| Sucralfate | 15 | $1,572 | $105 |
| Cholestyramine | 20 | $1,092 | $55 |
| Peg-3350 and Electrolytes | 52 | $1,088 | $21 |
| Gavilyte-C | 25 | $378 | $15 |
| Omeprazole | 26 | $300 | $12 |
| Ciprofloxacin | 28 | $193 | $7 |
2020: 6 drugs
| Creon | 11 | $40,755 | $3,705 |
| Gavilyte-C | 47 | $1,023 | $22 |
| Cholestyramine | 11 | $543 | $49 |
| Omeprazole | 23 | $293 | $13 |
| Peg-3350 and Electrolytes | 13 | $284 | $22 |
| Ciprofloxacin | 28 | $189 | $7 |
2019: 3 drugs
| Gavilyte-C | 40 | $1,416 | $35 |
| Levofloxacin | 24 | $170 | $7 |
| Ciprofloxacin | 15 | $106 | $7 |
2018: 2 drugs
| Omeprazole | 22 | $163 | $7 |
| Pantoprazole | 17 | $118 | $7 |
2017: 3 drugs
| Pantoprazole | 12 | $245 | $20 |
| Omeprazole | 18 | $202 | $11 |
| Gavilyte-G | 12 | $179 | $15 |
2016: 1 drug
| Omeprazole | 16 | $128 | $8 |
2015: 11 drugs
| Omeprazole | 23 | $219 | $10 |
| Metoprolol | 18 | $217 | $12 |
| Pravastatin | 12 | $208 | $17 |
| Amlodipine Besylate | 37 | $181 | $5 |
| Atorvastatin | 14 | $159 | $11 |
| Levothyroxine | 11 | $154 | $14 |
| Enalapril Maleate | 11 | $125 | $11 |
| Lisinopril | 14 | $115 | $8 |
| Furosemide | 20 | $94 | $5 |
| Hydrochlorothiazide | 11 | $44 | $4 |
| Metformin | 13 | $37 | $3 |
2014: 3 drugs
| Metoprolol | 13 | $75 | $6 |
| Furosemide | 12 | $58 | $5 |
| Metformin | 13 | $50 | $4 |
2013: 6 drugs
| Metoprolol | 30 | $212 | $7 |
| Enalapril Maleate | 19 | $189 | $10 |
| Furosemide | 20 | $127 | $6 |
| Pantoprazole | 12 | $121 | $10 |
| Metformin | 13 | $118 | $9 |
| Amlodipine Besylate | 13 | $85 | $7 |
Money from drug and device companies
$7,925 in 2025
| 2025 | 1 | 10 | $7,650 | $7,925 |
| 2024 | 2 | 23 | $10,625 | $12,780 |
| 2023 | 2 | 13 | None | $2,477 |
| 2022 | 1 | 1 | None | $17 |
| 2021 | 1 | 1 | None | $111 |
| 2019 | 1 | 5 | None | $327 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | X-Tack Endoscopic Helix Tacking System | $7,925 | 10 payments
|
See all 10 published payments
| Boston Scientific | Paid to speak or teach · 2025-10-09 | X-Tack Endoscopic Helix Tacking System | $850 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | X-Tack Endoscopic Helix Tacking System | $850 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | X-Tack Endoscopic Helix Tacking System | $425 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | X-Tack Endoscopic Helix Tacking System | $2,550 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | Axios | $850 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | Axios | $850 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | Axios | $850 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | Axios | $425 |
| Boston Scientific | Meals · 2025-09-20 | Resolution 360 Clip | $147 |
| Boston Scientific | Meals · 2025-09-09 | Axios | $128 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $12,780
| Boston Scientific | Exalt Model D | $12,695 | 22 payments
|
| Fujifilm Healthcare Americas | Fujifilm | $85 | 1 payment
|
2023: $2,477
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $1,614 | 9 payments
|
| Boston Scientific | None | $863 | 4 payments
|
2022: $17
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $17 | 1 payment
|
2021: $111
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $111 | 1 payment
|
2019: $327
| Boston Scientific | Axios | $327 | 5 payments
|
Professional record
- NPI
- 1497014260
- Licence
- CA A153638, IA MD42320, TX BP10044545California A153638: Current · expires 2027-10-31Texas BP10044545: Permit Terminated
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 760 36th Ave, San Francisco, CA, 94121
- NPI first listed
- 2012-05-14
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 200 Hawkins Dr, Iowa City, IA, 52242
This office lists an electronic records connection.